Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Haya S KaseerMatthew Soto-ArenallDevang SanghaviJohn MossRobert RatzlaffSi M PhamPramod K GuruPublished in: Journal of cardiac surgery (2020)
This study suggests that UFH and bivalirudin are associated with similar rates of thrombosis, major bleeding, and mortality events in patients supported by ECMO. However, it was observed that bivalirudin consistently maintained aPTT within the therapeutic range in comparison to UFH.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- percutaneous coronary intervention
- end stage renal disease
- atrial fibrillation
- respiratory failure
- venous thromboembolism
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- pulmonary embolism
- mechanical ventilation
- cardiovascular events
- risk factors
- acute coronary syndrome